kfm 19 has been researched along with kf 17837 in 1 studies
Studies (kfm 19) | Trials (kfm 19) | Recent Studies (post-2010) (kfm 19) | Studies (kf 17837) | Trials (kf 17837) | Recent Studies (post-2010) (kf 17837) |
---|---|---|---|---|---|
6 | 0 | 0 | 8 | 0 | 0 |
Protein | Taxonomy | kfm 19 (IC50) | kf 17837 (IC50) |
---|---|---|---|
Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.062 | |
Adenosine receptor A2a | Homo sapiens (human) | 0.001 | |
Adenosine receptor A2b | Homo sapiens (human) | 1.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fuse, E; Ichikawa, S; Ishii, A; Kobayashi, H; Nakamura, J; Nonaka, H; Shimada, J; Shiozaki, S; Suzuki, F | 1 |
1 other study(ies) available for kfm 19 and kf 17837
Article | Year |
---|---|
Adenosine A1 antagonists. 3. Structure-activity relationships on amelioration against scopolamine- or N6-((R)-phenylisopropyl)adenosine-induced cognitive disturbance.
Topics: Adenosine; Amnesia; Animals; Avoidance Learning; Diuretics; Male; Mice; Motor Activity; Phenylisopropyladenosine; Rats; Rats, Wistar; Receptors, Purinergic; Scopolamine; Structure-Activity Relationship; Xanthines | 1993 |